Treatment Differences by Health Insurance Among Outpatients With Coronary Artery Disease
Abstract
No abstract availableKeywords
Funding Information
- American Heart Association Pharmaceutical Roundtable and David and Stevie Spina (0875149N)
- Netherlands Organization for Scientific Research (VENI 916.11.179)
- W.L. Gore & Associates, Inc.
- National Heart Lung and Blood Institute (K23HL102224)
This publication has 37 references indexed in Scilit:
- Impact of Free Universal Medical Coverage on Medical Care and Outcomes in Low-Income Patients Hospitalized for Acute Myocardial InfarctionCirculation: Cardiovascular Quality and Outcomes, 2011
- The Effects of Financial Pressures on Adherence and Glucose Control Among Racial/Ethnically Diverse Patients with DiabetesJournal of General Internal Medicine, 2011
- Use of Prescription Drug Samples and Patient Assistance Programs, and the Role of Doctor–Patient CommunicationJournal of General Internal Medicine, 2011
- Identifying Patients at Risk for Premature Discontinuation of Thienopyridine After Coronary Stent ImplantationThe American Journal of Cardiology, 2011
- Health Insurance and Cardiovascular Disease Risk FactorsThe American Journal of Medicine, 2010
- Cardiac Performance Measure Compliance in OutpatientsJACC, 2010
- Cost-Effectiveness of Providing Full Drug Coverage to Increase Medication Adherence in Post–Myocardial Infarction Medicare BeneficiariesCirculation, 2008
- Risk of Cardiovascular Events and Death—Does Insurance Matter?Journal of General Internal Medicine, 2007
- Health Insurance Coverage and the Risk of Decline in Overall Health and Death Among the Near Elderly, 1992–2002Medical Care, 2006
- Lack of Health Insurance and Decline in Overall Health in Late Middle AgeNew England Journal of Medicine, 2001